MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microrna-mediated expression regulation is altered by a genetic variant

Journal of Biological Chemistry

Volumn 289, Issue 19, 2014, Pages 13434-13444

  Shi, Sandra ^a,b   Leites, Catherine ^a   He, Deli ^a   Schwartz, Daniel ^a   Moy, Winton ^a   Shi, Jianxin ^c   Duan, Jubao ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BRAIN; CELL CULTURE; DISEASES; NEURONS; STEM CELLS;

CHINESE HAMSTER OVARY; EXPRESSION REGULATION; HUMAN-INDUCED PLURIPOTENT STEM CELLS; LUCIFERASE ACTIVITIES; NEUROPSYCHIATRIC DISORDER; POST-TRANSCRIPTIONAL REGULATIONS; POTENTIAL DRUG TARGETS; UNTRANSLATED REGIONS;

RNA;

DOPAMINE 2 RECEPTOR; MICRORNA; MICRORNA 326; MICRORNA 9; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME REPRESSION; ENZYME SYNTHESIS; EX VIVO STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MOLECULAR CLONING; MUTAGENESIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

DOPAMINE RECEPTORS; DRD2; GENE EXPRESSION; GENE REGULATION; GENETIC POLYMORPHISM; MICRORNA; PHARMACOGENETICS;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84900457886     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.535203     Document Type: Article

References (83)

1. Carlsson, A., and Lindqvist, M. (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140-144
2. Creese, I., Burt, D. R., and Snyder, S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483
3. Seeman, P., and Lee, T. (1975) Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188, 1217-1219
4. Lieberman, J. A., Kane, J. M., and Alvir, J. (1987) Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91, 415-433
5. Snyder, S. H. (1976) The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry 133, 197-202
6. Snyder, S. H. (1974) Proceedings: drugs, neurotransmitters, and psychosis. Psychopharmacol. Bull. 10, 4-5
7. Seeman, P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152
8. Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., and Kapur, S. (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. Gen. Psychiatry 69, 776-786
9. Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., and Tanaka, C. (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol. Psychiatry 21, 1407-1414
10. Abi-Dargham, A., and Laruelle, M. (2005) Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur. Psychiatry 20, 15-27
11. Seeman, P., and Kapur, S. (2000) Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U. S. A. 97, 7673-7675
12. Mackay, A. V., Iversen, L. L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I., and Synder, S. H. (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry 39, 991-997
13. Zakzanis, K. K., and Hansen, K. T. (1998) Dopamine D2 densities and the schizophrenic brain. Schizophr. Res. 32, 201-206
14. Goldsmith, S. K., Shapiro, R. M., and Joyce, J. N. (1997) Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study. Arch. Gen. Psychiatry 54, 649-658
15. Tallerico, T., Novak, G., Liu, I. S., Ulpian, C., and Seeman, P. (2001) Schizophrenia: elevated mRNA for dopamine D2 (Longer) receptors in frontal cortex. Brain Res. Mol. Brain Res. 87, 160-165
16. Abi-Dargham, A., Gil, R., Krystal, J., Baldwin, R. M., Seibyl, J. P., Bowers, M., Van Dyck, C. H., Charney, D. S., Innis, R. B., and Laruelle, M. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761-767
17. Laruelle, M., Abi-Dargham, A., Van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., Baldwin, R. M., Seibyl, J. P., Krystal, J. H., Charney, D. S., and Innis, R. B. (1996) Single photon emission computerized tomography imaging of amphetamineinduced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U. S. A. 93, 9235-9240
18. Breier, A., Su, T. P., Saunders, R., Carson, R. E., Kolachana, B. S., De Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., and Pickar, D. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U. S. A. 94, 2569-2574
19. Farde, L., Nordström, A. L., Wiesel, F. A., Pauli, S., Halldin, C., and Sedvall, G. (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch. Gen. Psychiatry 49, 538-544
20. Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., and Kandel, E. R. (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49, 603-615
21. Li, Y. C., Kellendonk, C., Simpson, E. H., Kandel, E. R., and Gao, W. J. (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 108, 12107-12112
22. Gejman, P. V., Ram, A., Gelernter, J., Friedman, E., Cao, Q., Pickar, D., Blum, K., Noble, E. P., Kranzler, H. R., and O'Malley, S. (1994) No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 271, 204-208
23. Cravchik, A., Sibley, D. R., and Gejman, P. V. (1996) Functional analysis of the human D2 dopamine receptor missense variants. J. Biol. Chem. 271, 26013-26017
24. Glatt, S. J., Faraone, S. V., and Tsuang, M. T. (2003) Meta-Analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol. Psychiatry 8, 911-915
25. Volkow, N. D., Fowler, J. S., Wang, G. J., Swanson, J. M., and Telang, F. (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64, 1575-1579
26. Sipilä, T., Kananen, L., Greco, D., Donner, J., Silander, K., Terwilliger, J. D., Auvinen, P., Peltonen, L., Lönnqvist, J., Pirkola, S., Partonen, T., and Hovatta, I. (2010) An association analysis of circadian genes in anxiety disorders. Biol. Psychiatry 67, 1163-1170
27. Jönsson, E. G., Cichon, S., Gustavsson, J. P., Grünhage, F., Forslund, K., Mattila-Evenden, M., Rylander, G., Asberg, M., Farde, L., Propping, P., and Nöthen, M. M. (2003) Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment. Biol. Psychiatry 53, 577-584
28. Arinami, T., Gao, M., Hamaguchi, H., and Toru, M. (1997) A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol. Genet. 6, 577-582
29. Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M. L., Xiao, T., Papp, A., Wang, D., and Sadée, W. (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. U. S. A. 104, 20552-20557
30. Moyer, R. A., Wang, D., Papp, A. C., Smith, R. M., Duque, L., Mash, D. C., and Sadee, W. (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36, 753-762
31. Sullivan, D., Pinsonneault, J. K., Papp, A. C., Zhu, H., Lemeshow, S., Mash, D. C., and Sadee, W. (2013) Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction. Transl. psychiatry 3, e222
32. Duan, J., Wainwright, M. S., Comeron, J. M., Saitou, N., Sanders, A. R., Gelernter, J., and Gejman, P. V. (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol. Genet. 12, 205-216
33. Hirvonen, M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., and Hietala, J. (2004) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol. Psychiatry 9, 1060-1061
34. Rodriguez-Jimenez, R., Hoenicka, J., Jimenez-Arriero, M. A., Ponce, G., Bagney, A., Aragues, M., and Palomo, T. (2006) Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology 54, 166-170
35. Frank, M. J., Moustafa, A. A., Haughey, H. M., Curran, T., and Hutchison, K. E. (2007) Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc. Natl. Acad. Sci. U. S. A. 104, 16311-16316
36. Jacobsen, L. K., Pugh, K. R., Mencl, W. E., and Gelernter, J. (2006) C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology 188, 530-540
37. Voisey, J., Swagell, C. D., Hughes, I. P., Barnes, M., Burton, S. C., Van Daal, A., Morris, C. P., Lawford, B. R., and Young, R. M. (2010) A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics. Psychiatry Res. 177, 367-368
38. Whitmer, A. J., and Gotlib, I. H. (2012) Depressive rumination and the C957T polymorphism of the DRD2 gene. Cogn. Affect. Behav. Neurosci. 12, 741-747
39. Zeng, Y., Yi, R., and Cullen, B. R. (2005) Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 24, 138-148
40. Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M., and Lai, E. C. (2007) The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130, 89-100
41. Djuranovic, S., Nahvi, A., and Green, R. (2012) miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237-240
42. Pasquinelli, A. E. (2012) MicroRNAs and their targets: recognition, regulation, and an emerging reciprocal relationship. Nat. Rev. Genet. 13, 271-282
43. Duan, J., Shi, J., Ge, X., Dölken, L., Moy, W., He, D., Shi, S., Sanders, A. R., Ross, J., and Gejman, P. V. (2013) Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci. Rep. 3, 1318
44. Yuva-Aydemir, Y., Simkin, A., Gascon, E., and Gao, F. B. (2011) MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol. 8, 557-564
45. Kefas, B., Comeau, L., Floyd, D. H., Seleverstov, O., Godlewski, J., Schmittgen, T., Jiang, J., Di Pierro, C. G., Li, Y., Chiocca, E. A., Lee, J., Fine, H., Abounader, R., Lawler, S., and Purow, B. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J. Neurosci. 29, 15161-15168
46. Ferretti, E., De Smaele, E., Miele, E., Laneve, P., Po, A., Pelloni, M., Paganelli, A., Di Marcotullio, L., Caffarelli, E., Screpanti, I., Bozzoni, I., and Gulino, A. (2008) Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 27, 2616-2627
47. Zhang, L. J., Lachowicz, J. E., and Sibley, D. R. (1994) The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45, 878-889
48. Sanders, A. R., Duan, J., Levinson, D. F., Shi, J., He, D., Hou, C., Burrell, G. J., Rice, J. P., Nertney, D. A., Olincy, A., Rozic, P., Vinogradov, S., Buccola, N. G., Mowry, B. J., Freedman, R., Amin, F., Black, D. W., Silverman, J. M., Byerley, W. F., Crowe, R. R., Cloninger, C. R., Martinez, M., and Gejman, P. V. (2008) No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 165, 497-506
49. Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., Olincy, A., Amin, F., Cloninger, C. R., Silverman, J. M., Buccola, N. G., Byerley, W. F., Black, D. W., Crowe, R. R., Oksenberg, J. R., Mirel, D. B., Kendler, K. S., Freedman, R., and Gejman, P. V. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757
50. Sommer, C. A., Sommer, A. G., Longmire, T. A., Christodoulou, C., Thomas, D. D., Gostissa, M., Alt, F. W., Murphy, G. J., Kotton, D. N., and Mostoslavsky, G. (2010) Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64-74
51. Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., and Mostoslavsky, G. (2009) Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543-549
52. Park, I. H., and Daley, G. Q. (2009) Human iPS cell derivation/ reprogramming. Curr. Protoc. Stem Cell Biol., 10.1002/9780470151808.sc04a01s8
53. Kriks, S., Shim, J. W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., Yang, L., Beal, M. F., Surmeier, D. J., Kordower, J. H., Tabar, V., and Studer, L. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551
54. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675
55. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20
56. Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., Da Piedade, I., Gunsalus, K. C., Stoffel, M., and Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500
57. Rehmsmeier, M., Steffen, P., Hochsmann, M., and Giegerich, R. (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517
58. Barrett, J. C., Fry, B., Maller, J., and Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265
59. Misiuta, I. E., Saporta, S., Sanberg, P. R., Zigova, T., and Willing, A. E. (2006) Influence of retinoic acid and lithium on proliferation and dopaminergic potential of human NT2 cells. J Neurosci. Res. 83, 668-679
60. Sodja, C., Fang, H., Dasgupta, T., Ribecco, M., Walker, P. R., and Sikorska, M. (2002) Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Brain Res. Mol. Brain Res. 99, 83-91
61. Gunter, K. K., Aschner, M., Miller, L. M., Eliseev, R., Salter, J., Anderson, K., and Gunter, T. E. (2006) Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging 27, 1816-1826
62. Fang, H., Chartier, J., Sodja, C., Desbois, A., Ribecco-Lutkiewicz, M., Walker, P. R., and Sikorska, M. (2003) Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons. J. Biol. Chem. 278, 26401-26409
63. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., and Wang, D. Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233
64. Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., and Greenberg, M. E. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289
65. Kuhn, D. E., Martin, M. M., Feldman, D. S., Terry, A. V., Jr., Nuovo, G. J., and Elton, T. S. (2008) Experimental validation of miRNA targets. Methods 44, 47-54
66. Thomson, D. W., Bracken, C. P., and Goodall, G. J. (2011) Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853
67. Gennarino, V. A., D'Angelo, G., Dharmalingam, G., Fernandez, S., Russolillo, G., Sanges, R., Mutarelli, M., Belcastro, V., Ballabio, A., Verde, P., Sardiello, M., and Banfi, S. (2012) Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res. 22, 1163-1172
68. Volk, D. W., and Lewis, D. A. (2010) Prefrontal cortical circuits in schizophrenia. Curr. Top. Behav. Neurosci. 4, 485-508
69. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976
70. Ripke, S., et al. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159
71. Zhao, C., Sun, G., Ye, P., Li, S., and Shi, Y. (2013) MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis. Sci. Rep. 3, 1329
72. Sun, G., Ye, P., Murai, K., Lang, M. F., Li, S., Zhang, H., Li, W., Fu, C., Yin, J., Wang, A., Ma, X., and Shi, Y. (2011) miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nat. Commun. 2, 529
73. Kwon, E., Wang, W., and Tsai, L. H. (2013) Validation of schizophreniaassociated genes CSMD1, C10orf26, CACNA1C, and TCF4 as miR-137 targets. Mol. Psychiatry 18, 11-12
74. Kim, A. H., Parker, E. K., Williamson, V., McMichael, G. O., Fanous, A. H., and Vladimirov, V. I. (2012) Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr. Res. 141, 60-64
75. Girgenti, M. J., Lo Turco, J. J., and Maher, B. J. (2012) ZNF804a regulates expression of the schizophrenia-Associated genes PRSS16, COMT, PDE4B, and DRD2. PLoS ONE 7, e32404
76. Guella, I., Sequeira, A., Rollins, B., Morgan, L., Torri, F., Van Erp, T. G., Myers, R. M., Barchas, J. D., Schatzberg, A. F., Watson, S. J., Akil, H., Bunney, W. E., Potkin, S. G., Macciardi, F., and Vawter, M. P. (2013) Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J. Psychiatr Res. 47, 1215-1221
77. Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., Hatzigeorgiou, A. G., and Antonarakis, S. E. (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 81, 405-413
78. Tan, Z., Randall, G., Fan, J., Camoretti-Mercado, B., Brockman-Schneider, R., Pan, L., Solway, J., Gern, J. E., Lemanske, R. F., Nicolae, D., and Ober, C. (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81, 829-834
79. Landi, D., Gemignani, F., Naccarati, A., Pardini, B., Vodicka, P., Vodickova, L., Novotny, J., Försti, A., Hemminki, K., Canzian, F., and Landi, S. (2008) Polymorphisms within micro-RNA binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29, 579-584
80. Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E., Wu, M., and Shen, S. H. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 35, 4535-4541
81. Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rasin, M. R., Gunel, M., Davis, N. R., Ercan-Sencicek, A. G., Guez, D. H., Spertus, J. A., Leckman, J. F., Dure, L. S., 4th, Kurlan, R., Singer, H. S., Gilbert, D. L., Farhi, A., Louvi, A., Lifton, R. P., Sestan, N., and State, M. W. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320
82. Farde, L., Gustavsson, J. P., and Jönsson, E. (1997) D2 dopamine receptors and personality traits. Nature 385, 590
83. Tritsch, N. X., and Sabatini, B. L. (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76, 33-50